These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 2585837

  • 1. [The effects of intravenous infused magnesium on hemodynamics and renal water-sodium metabolism in patients with essential hypertension].
    Ohtomo T, Kikuchi K, Komura H, Nozawa A, Hasegawa T, Suzuki S, Satoh N, Takada T, Iimura O.
    Nihon Jinzo Gakkai Shi; 1989 Sep; 31(9):977-84. PubMed ID: 2585837
    [Abstract] [Full Text] [Related]

  • 2. [Effects of intravenously infused magnesium on renal calcium metabolism and plasma parathyroid hormone in patients with essential hypertension].
    Satoh N, Kikuchi K, Komura H, Suzuki S, Ohtomo T, Takada T, Nanba M, Marusaki S, Iimura O.
    Nihon Jinzo Gakkai Shi; 1992 Jun; 34(6):743-51. PubMed ID: 1479714
    [Abstract] [Full Text] [Related]

  • 3. [The role of the Na, K-ATPase inhibitor in renal sodium handling in patients with essential hypertension].
    Komura H, Kikuchi K, Nozawa A, Hasegawa T, Suzuki S, Yamamoto M, Satoh N, Ohtomo T, Takada T, Iimura O.
    Nihon Jinzo Gakkai Shi; 1989 Jul; 31(7):775-81. PubMed ID: 2555614
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic and natriuretic responses to intravenous infusion of dopamine in patients with essential hypertension.
    Kikuchi K, Miyama A, Nakao T, Takigami Y, Kondo A, Mito T, Ura N, Tsuzuki M, Iimura O.
    Jpn Circ J; 1982 May; 46(5):486-93. PubMed ID: 7043016
    [Abstract] [Full Text] [Related]

  • 5. The pathophysiological role of renal dopaminergic activity in patients with essential hypertension.
    Iimura O, Yamaji I, Kikuchi K, Shibata S, Nishimura M, Nozawa A, Aoki K, Hasegawa T, Kobayakawa H, Komura H.
    Jpn Circ J; 1987 Oct; 51(10):1232-40. PubMed ID: 3323560
    [Abstract] [Full Text] [Related]

  • 6. The pathophysiological role of water-sodium balance and renal dopaminergic activity in overweight patients with essential hypertension.
    Kikuchi K, Iimura O, Yamaji I, Shibata S, Nishimura M, Aoki K, Nozawa A, Hasegawa T, Honma C, Kobayakawa H.
    J Clin Hypertens; 1987 Mar; 3(1):3-11. PubMed ID: 3572460
    [Abstract] [Full Text] [Related]

  • 7. [The role of the renal dopaminergic and the prostaglandin systems in renal uric acid metabolism in patients with essential hypertension].
    Satoh N, Kikuchi K, Hasegawa T, Komura H, Suzuki S, Ohtomo T, Takada T, Nanba M, Marusaki S, Iimura O.
    Nihon Naibunpi Gakkai Zasshi; 1991 Nov 20; 67(11):1271-81. PubMed ID: 1761141
    [Abstract] [Full Text] [Related]

  • 8. [Renal sodium handling and renal dopaminergic activity in overweight normotensive subjects].
    Kudoh C, Kikuchi K, Yamaji I, Kobayakawa H, Yamamoto M, Shimazaki M, Sakamoto T, Wada A, Sawai N, Mukai H.
    Nihon Naibunpi Gakkai Zasshi; 1991 Jun 20; 67(6):682-91. PubMed ID: 1889510
    [Abstract] [Full Text] [Related]

  • 9. The role of renal kallikrein-kinin system and prostaglandins in diuresis and natriuresis following saline infusion in normotensives and essential hypertensives.
    Nishimiya T, Shimamoto K, Tanaka S, Ura N, Mita T, Nakagawa M, Maeda T, Yamaguchi Y, Masuca A, Iimura O.
    Adv Exp Med Biol; 1986 Jun 20; 198 Pt B():337-42. PubMed ID: 3643730
    [Abstract] [Full Text] [Related]

  • 10. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM, de Zeeuw D, van der Hem GK, de Jong PE.
    J Hypertens; 1994 Apr 20; 12(4):439-47. PubMed ID: 8064168
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS, Clark KL, Johns EJ, Drew GM.
    Br J Pharmacol; 1998 Aug 20; 124(7):1467-74. PubMed ID: 9723960
    [Abstract] [Full Text] [Related]

  • 17. Effects of nisoldipine on sympathetic activity, the renin-angiotensin-aldosterone system, and water-sodium-calcium metabolism in patients with essential hypertension.
    Iimura O, Kikuchi K, Shimamoto K, Nozawa A, Hasegawa R, Homma C, Komura H, Kobayakawa H.
    Arzneimittelforschung; 1989 Jun 20; 39(6):710-4. PubMed ID: 2775339
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The haemodynamic, renal and endocrine effects of alpha-human atrial natriuretic polypeptide in normotensive people and patients with essential hypertension.
    Ishii M, Sugimoto T, Matsuoka H, Hirata Y, Ishimistu T, Fukui K, Sugimoto T, Kangawa K, Matsuo H.
    J Hypertens Suppl; 1986 Dec 20; 4(6):S542-5. PubMed ID: 2956389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.